Trial Profile
To compare the anti-inflammatory effect of atorvastatin and rosuvastatin in the patients of acute coronary syndrome.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- 13 Mar 2013 New trial record